Thiolation of Q295: Site-Specific Conjugation of Hydrophobic Payloads without the Need for Genetic Engineering-Reference-Cited by-同舟云学术

Thiolation of Q295: Site-Specific Conjugation of Hydrophobic Payloads without the Need for Genetic Engineering

Published:2019-05-08 Issue:6 Volume:16 Page:2795-2807
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Benjamin Samantha R.¹,Jackson Courtney P.¹,Fang Siteng¹,Carlson Dane P.¹,Guo Zhongyuan¹,Tumey L. Nathan¹^ORCID

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences, Binghamton University, P.O. Box 6000, Binghamton, New York 13902, United States

Funder

SUNY research foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00323

Reference53 articles.

1. Drawing lessons from the clinical development of antibody-drug conjugates

2. A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

3. Investigational CD33-targeted therapeutics for acute myeloid leukemia

4. AbbVie takes $4B hit on Rova-T failures | FierceBiotech https://www.fiercebiotech.com/biotech/abbvie-takes-4b-hit-rova-t-failures (accessed Feb 18, 2019).

5. Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First site-specific conjugation method for native goat IgG antibodies via glycan remodeling at the conserved Fc region;Antibody Therapeutics;2024-07

2. A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin cleavable ADC linkers;Xenobiotica;2024-05-13

3. Toxic warhead-armed antibody for targeted treatment of glioblastoma;Critical Reviews in Oncology/Hematology;2024-01

4. Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody–Drug Conjugates;Antibodies;2023-11-03

5. Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1;Molecular and Cellular Biochemistry;2023-05-02